FimmCyte raised €1.0M in a Debt round in Feb 2024. The company is based in Basel, Switzerland. Investors in the round: UZH Life Sciences Fund (LSF). Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
